Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response.
Marconato M, Abela IA, Hauser A, Schwarzmüller M, Katzensteiner R, Braun DL, Epp S, Audigé A, Weber J, Rusert P, Schindler E, Pasin C, West E, Böni J, Kufner V, Huber M, Zaheri M, Schmutz S, Frey BM, Kouyos RD, Günthard HF, Manz MG, Trkola A.
Marconato M, et al. Among authors: pasin c.
J Clin Invest. 2022 Jun 15;132(12):e158190. doi: 10.1172/JCI158190.
J Clin Invest. 2022.
PMID: 35482408
Free PMC article.
Clinical Trial.